• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国国家肾脏基金会关于心血管疾病和肾脏疾病及糖尿病风险的共识会议:减少事件的综合治疗方法。

National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce events.

机构信息

Department of Medicine, University of Chicago, Pritzker School of Medicine, Chicago, Illinois 60637, USA.

出版信息

Kidney Int. 2010 Oct;78(8):726-36. doi: 10.1038/ki.2010.292. Epub 2010 Aug 18.

DOI:10.1038/ki.2010.292
PMID:20720529
Abstract

Cardiovascular disease (CVD) is the most common cause of death in industrialized nations. Type 2 diabetes is a CVD risk factor that confers risk similar to a previous myocardial infarction in an individual who does not have diabetes. In addition, the most common cause of chronic kidney disease (CKD) is diabetes. Together, diabetes and hypertension account for more than two-thirds of CVD risk, and other risk factors such as dyslipidemia contribute to the remainder of CVD risk. CKD, particularly with presence of significant albuminuria, should be considered an additional cardiovascular risk factor. There is no consensus on how to assess and stratify risk for patients with kidney disease across subspecialties that commonly treat such patients. This paper summarizes the results of a consensus conference utilizing a patient case to discuss the integrated management of hypertension, kidney disease, dyslipidemia, diabetes, and heart failure across disciplines.

摘要

心血管疾病(CVD)是工业化国家中最常见的死亡原因。2 型糖尿病是 CVD 的一个危险因素,它在没有糖尿病的个体中赋予与先前心肌梗死相似的风险。此外,慢性肾脏病(CKD)的最常见原因是糖尿病。糖尿病和高血压共同导致超过三分之二的 CVD 风险,而其他危险因素如血脂异常则导致剩余的 CVD 风险。CKD,特别是伴有大量白蛋白尿,应被视为另一个心血管危险因素。在通常治疗此类患者的各个亚专业中,对于患有肾脏病的患者如何进行评估和分层风险尚无共识。本文总结了一次共识会议的结果,该会议利用一个患者病例讨论了各学科之间高血压、肾脏病、血脂异常、糖尿病和心力衰竭的综合管理。

相似文献

1
National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce events.美国国家肾脏基金会关于心血管疾病和肾脏疾病及糖尿病风险的共识会议:减少事件的综合治疗方法。
Kidney Int. 2010 Oct;78(8):726-36. doi: 10.1038/ki.2010.292. Epub 2010 Aug 18.
2
Cardiovascular risk factors in patients with chronic kidney disease.慢性肾病患者的心血管危险因素
Nat Rev Cardiol. 2009 Sep;6(9):580-9. doi: 10.1038/nrcardio.2009.121. Epub 2009 Jul 21.
3
[Chronic kidney disease (CKD) as an independent risk factor for cardiovascular disease (CVD)].[慢性肾脏病(CKD)作为心血管疾病(CVD)的独立危险因素]
Nihon Rinsho. 2008 Sep;66(9):1657-63.
4
ESH-ESC guidelines for the management of hypertension.欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)高血压管理指南
Herz. 2006 Jun;31(4):331-8. doi: 10.1007/s00059-006-2829-3.
5
Management of dyslipidemias in patients with diabetes and chronic kidney disease.糖尿病和慢性肾脏病患者血脂异常的管理
Clin J Am Soc Nephrol. 2006 Sep;1(5):1090-9. doi: 10.2215/CJN.00780306. Epub 2006 Jul 26.
6
[Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].[慢性肾脏病中的高血压、血脂异常与心血管风险]
Ital Heart J Suppl. 2004 Jun;5(6):436-44.
7
Management of cardiovascular disease risk in teens with type 1 diabetes: Perspectives of teens with and without dyslipidemia and parents.青少年 1 型糖尿病患者心血管疾病风险的管理:伴有和不伴有血脂异常的青少年以及家长的观点。
Pediatr Diabetes. 2019 Mar;20(2):210-216. doi: 10.1111/pedi.12771.
8
Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者血脂异常作为心血管危险因素的管理。
Clin Gastroenterol Hepatol. 2014 Jul;12(7):1077-84; quiz e59-60. doi: 10.1016/j.cgh.2013.08.014. Epub 2013 Aug 17.
9
Kidney Disease in Diabetes糖尿病肾病
10
Management of hyperglycemia, dyslipidemia, and albuminuria in patients with diabetes and CKD: a systematic review for a KDOQI clinical practice guideline.糖尿病和 CKD 患者的高血糖、血脂异常和白蛋白尿管理:一项 KDOQI 临床实践指南的系统评价。
Am J Kidney Dis. 2012 Nov;60(5):747-69. doi: 10.1053/j.ajkd.2012.07.017. Epub 2012 Sep 19.

引用本文的文献

1
The Controversies of Coronary Artery Disease in End-Stage Kidney Disease Patients: A Narrative Review.终末期肾病患者冠状动脉疾病的争议:一项叙述性综述
Rev Cardiovasc Med. 2023 Jun 25;24(6):181. doi: 10.31083/j.rcm2406181. eCollection 2023 Jun.
2
Attenuating effects of fractions on glycemo-impaired-associated dyslipidemia, hepatopathy, and nephropathy.各组分对糖代谢受损相关血脂异常、肝病和肾病的减轻作用。
Am J Transl Res. 2023 Oct 15;15(10):5997-6014. eCollection 2023.
3
p53 and Myofibroblast Apoptosis in Organ Fibrosis.p53 与肌成纤维细胞凋亡在器官纤维化中的作用。
Int J Mol Sci. 2023 Apr 4;24(7):6737. doi: 10.3390/ijms24076737.
4
Epoxyeicosatrienoic acid administration or soluble epoxide hydrolase inhibition attenuates renal fibrogenesis in obstructive nephropathy.给予环氧二十碳三烯酸或抑制可溶性环氧化物水解酶可减轻梗阻性肾病中的肾纤维化。
Am J Physiol Renal Physiol. 2023 Feb 1;324(2):F138-F151. doi: 10.1152/ajprenal.00052.2022. Epub 2022 Dec 8.
5
Blood pressure and proteinuria control remains a challenge in patients with type 2 diabetes mellitus and chronic kidney disease: experience from the prospective observational ALICE-PROTECT study.血压和蛋白尿控制在2型糖尿病合并慢性肾脏病患者中仍然是一项挑战:来自前瞻性观察性ALICE-PROTECT研究的经验
BMC Nephrol. 2016 Sep 21;17(1):135. doi: 10.1186/s12882-016-0336-1.
6
Genetics of cardiovascular and renal complications in diabetes.糖尿病心血管及肾脏并发症的遗传学
J Diabetes Investig. 2016 Mar;7(2):139-54. doi: 10.1111/jdi.12391. Epub 2015 Aug 26.
7
Simultaneous deletion of Bax and Bak is required to prevent apoptosis and interstitial fibrosis in obstructive nephropathy.在梗阻性肾病中,需要同时缺失Bax和Bak才能预防细胞凋亡和间质纤维化。
Am J Physiol Renal Physiol. 2015 Sep 15;309(6):F540-50. doi: 10.1152/ajprenal.00170.2015. Epub 2015 Jul 15.
8
Molecular phenotyping of clinical AKI with novel urinary biomarkers.采用新型尿液生物标志物对临床急性肾损伤进行分子表型分析。
Am J Physiol Renal Physiol. 2015 Sep 1;309(5):F406-13. doi: 10.1152/ajprenal.00682.2014. Epub 2015 Jun 17.
9
A Cluster of Proteins Implicated in Kidney Disease Is Increased in High-Density Lipoprotein Isolated from Hemodialysis Subjects.从血液透析患者分离出的高密度脂蛋白中,与肾脏疾病相关的一组蛋白质增加。
J Proteome Res. 2015 Jul 2;14(7):2792-806. doi: 10.1021/acs.jproteome.5b00060. Epub 2015 Jun 15.
10
Serum hepcidin predicts uremic accelerated atherosclerosis in chronic hemodialysis patients with diabetic nephropathy.血清铁调素可预测糖尿病肾病慢性血液透析患者的尿毒症加速动脉粥样硬化。
Chin Med J (Engl). 2015 May 20;128(10):1351-7. doi: 10.4103/0366-6999.156781.